Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Found 10683 matches for

Friday 14 February was the day of our annual visit to Oxford's Department of Education to spend some time with their trainee teachers.

EMERALD Pancreas: Evaluation of hypofractionated adaptive radiotherapy using the MR Linac in localised pancreatic cancer

Designing Novel Vectors for Targeted In Vivo Transduction of Monocytes to Deliver Cancer Therapeutics into the Tumour Microenvironment

Student Interviews

The paradox of AMER1 driver mutations in colorectal cancer

Developing a neoantigen-like, ROP-based vaccine targeting SVN (ROP-SVN) to boost host immune responses

Tumour avatars of patients for assessment of therapeutic efficacy

Hippo signalling in Natural Killer Cells maturation and function

Hippo signalling in Natural Killer Cells maturation and function

60 seconds with...

Welcome

The Department of Oncology's mission is to improve cancer care through research and teaching. There is strong emphasis on translation, with established infrastructure to develop scientific insights toward clinical appreciation.

Identifying unique vulnerabilities of polyploid tumour cells to enhance radiation sensitivity

Course Overview

The MSc in Radiobiology is scheduled to run over one academic year as a full-time course consisting of eight compulsory taught modules and a research-based dissertation.

UKHSA project - Identifying biomarkers to prevent medical radiation toxicity: Role of Adipose tissue in skin toxicity during radiotherapy

Characterisation of the cross-talk between the hypoxia-induced DNA damage and unfolded protein responses

Developing a novel type of cancer vaccine for genetically-defined tumours

ARCADIAN: Atovaquone with Radical ChemorADIotherapy in locally Advanced NSCLC

Accelerator technology advancements enabling MV photon FLASH radiotherapy

Developing novel therapeutic strategies to improve radiotherapy

Elucidating the role of tumour microenvironment in breast cancer metastasis

The Fanconi anaemia pathway and cancer: a molecular dissection

Load More

Similar stories

MSc Medical Physics with Radiobiology receives IPEM accreditation

The Department of Oncology at the University of Oxford is delighted to announce that our new MSc Medical Physics with Radiobiology programme has received Masters Level Accreditation from the Institute of Physics and Engineering Medicine (IPEM).

Glowing dye helps surgeons eradicate prostate cancer

A glowing marker dye that sticks to prostate cancer cells could help surgeons to remove them in real-time, according to a study led by the University of Oxford.

Festive Science Image Competition Winners

Winners of the Medical Research Foundation's second Festive Science Image Competition, run in partnership with the Medical Research Council (MRC), have been announced today.

The Howat Foundation to fund Chair in Clinical Oncology

Oxford Cancer announce the endowment of a Chair in Clinical Oncology, thanks to generous philanthropic support from The Howat Foundation

Scientists find genetic ‘marker’ linked to serious side-effects from skin cancer treatment

New research from the Fairfax Group has identified a genetic marker that could be used to predict a patient’s risk of developing serious side-effects when undergoing immunotherapy treatment for metastatic melanoma.

MP Anneliese Dodds tours Oxford cancer research

Anneliese Dodds, MP for Oxford East & Chair of the Labour Party, visited the University of Oxford to learn more about the impactful work happening across departments in the field of cancer research.